{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:55:29Z","timestamp":1790722529615,"version":"4.1.0"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["12302012"],"award-info":[{"award-number":["12302012"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s12013-024-01464-w","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T20:32:24Z","timestamp":1722630744000},"page":"3223-3234","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Roles of RNA N6-methyladenosine Modifications in Systemic Lupus Erythematosus"],"prefix":"10.1007","volume":"82","author":[{"given":"Xin","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,2]]},"reference":[{"issue":"3","key":"1464_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/10408363.2021.2002256","volume":"59","author":"W Zhou","year":"2022","unstructured":"Zhou, W., et al. (2022). The molecular structure and biological functions of RNA methylation, with special emphasis on the roles of RNA methylation in autoimmune diseases. Critical Reviews in Clinical Laboratory Sciences, 59(3), 203\u2013218.","journal-title":"Critical Reviews in Clinical Laboratory Sciences"},{"issue":"1","key":"1464_CR2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s13075-023-03149-w","volume":"25","author":"Y Huang","year":"2023","unstructured":"Huang, Y., et al. (2023). M6A methylation modification in autoimmune diseases, a promising treatment strategy based on epigenetics. Arthritis Research & Therapy, 25(1), 189.","journal-title":"Arthritis Research & Therapy"},{"issue":"3","key":"1464_CR3","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1080\/08830185.2023.2280544","volume":"43","author":"L Li","year":"2024","unstructured":"Li, L., et al. (2024). RNA methylation: A potential therapeutic target in autoimmune disease. International Reviews of Immunology, 43(3), 160\u2013177.","journal-title":"International Reviews of Immunology"},{"issue":"10","key":"1464_CR4","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","volume":"20","author":"S Zaccara","year":"2019","unstructured":"Zaccara, S., Ries, R. J., & Jaffrey, S. R. (2019). Reading, writing and erasing mRNA methylation. Nature Reviews Molecular Cell Biology, 20(10), 608\u2013624.","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"8","key":"1464_CR5","doi-asserted-by":"publisher","first-page":"e20210279","DOI":"10.1084\/jem.20210279","volume":"218","author":"S Ma","year":"2021","unstructured":"Ma, S., et al. (2021). The RNA m6A reader YTHDF2 controls NK cell antitumor and antiviral immunity. Journal of Experimental Medicine, 218(8), e20210279.","journal-title":"Journal of Experimental Medicine"},{"issue":"7743","key":"1464_CR6","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-0916-x","volume":"566","author":"D Han","year":"2019","unstructured":"Han, D., et al. (2019). Anti-tumour immunity controlled through mRNA m(6)A methylation and YTHDF1 in dendritic cells. Nature, 566(7743), 270\u2013274.","journal-title":"Nature"},{"issue":"2","key":"1464_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2021.188522","volume":"1875","author":"M Li","year":"2021","unstructured":"Li, M., Zha, X., & Wang, S. (2021). The role of N6-methyladenosine mRNA in the tumor microenvironment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1875(2), 188522.","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"issue":"2","key":"1464_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41419-017-0129-x","volume":"9","author":"D Dai","year":"2018","unstructured":"Dai, D., et al. (2018). N6-methyladenosine links RNA metabolism to cancer progression. Cell Death & Disease, 9(2), 124.","journal-title":"Cell Death & Disease"},{"key":"1464_CR9","first-page":"6327614","volume":"2020","author":"YN Wang","year":"2020","unstructured":"Wang, Y. N., Yu, C. Y., & Jin, H. Z. (2020). RNA N(6)-Methyladenosine Modifications and the Immune Response. Journal of Immunology Research, 2020, 6327614.","journal-title":"Journal of Immunology Research"},{"issue":"1","key":"1464_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-02918-y","volume":"19","author":"C Liu","year":"2021","unstructured":"Liu, C., et al. (2021). Potential roles of N6-methyladenosine (m6A) in immune cells. Journal of Translational Medicine, 19(1), 251.","journal-title":"Journal of Translational Medicine"},{"key":"1464_CR11","doi-asserted-by":"publisher","first-page":"755691","DOI":"10.3389\/fcell.2021.755691","volume":"9","author":"Y Wang","year":"2021","unstructured":"Wang, Y., et al. (2021). The Emerging Role of m6A Modification in Regulating the Immune System and Autoimmune Diseases. Frontiers in Cell and Developmental Biology, 9, 755691.","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"2","key":"1464_CR12","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s12020-020-02503-1","volume":"72","author":"RH Song","year":"2021","unstructured":"Song, R. H., et al. (2021). METTL3 gene polymorphisms contribute to susceptibility to autoimmune thyroid disease. Endocrine, 72(2), 495\u2013504.","journal-title":"Endocrine"},{"issue":"2","key":"1464_CR13","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.advms.2021.07.006","volume":"66","author":"RH Song","year":"2021","unstructured":"Song, R. H., et al. (2021). Inclusion of ALKBH5 as a candidate gene for the susceptibility of autoimmune thyroid disease. Advances in Medical Sciences, 66(2), 351\u2013358.","journal-title":"Advances in Medical Sciences"},{"key":"1464_CR14","doi-asserted-by":"publisher","first-page":"5735279","DOI":"10.1155\/2020\/5735279","volume":"2020","author":"Q Luo","year":"2020","unstructured":"Luo, Q., et al. (2020). Decreased ALKBH5, FTO, and YTHDF2 in Peripheral Blood Are as Risk Factors for Rheumatoid Arthritis. BioMed Research International, 2020, 5735279.","journal-title":"BioMed Research International"},{"key":"1464_CR15","doi-asserted-by":"publisher","first-page":"607585","DOI":"10.3389\/fmed.2021.607585","volume":"8","author":"W Shi","year":"2021","unstructured":"Shi, W., et al. (2021). METTL3 Promotes Activation and Inflammation of FLSs Through the NF-kappaB Signaling Pathway in Rheumatoid Arthritis. Frontiers in Medicine (Lausanne), 8, 607585.","journal-title":"Frontiers in Medicine (Lausanne)"},{"key":"1464_CR16","doi-asserted-by":"publisher","first-page":"3120391","DOI":"10.1155\/2019\/3120391","volume":"2019","author":"J Wang","year":"2019","unstructured":"Wang, J., et al. (2019). METTL3 Attenuates LPS-Induced Inflammatory Response in Macrophages via NF-kappaB Signaling Pathway. Mediators of Inflammation, 2019, 3120391.","journal-title":"Mediators of Inflammation"},{"issue":"11","key":"1464_CR17","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1007\/s00415-019-09476-w","volume":"266","author":"XB Mo","year":"2019","unstructured":"Mo, X. B., et al. (2019). Integrative analysis revealed potential causal genetic and epigenetic factors for multiple sclerosis. Journal of Neurology, 266(11), 2699\u20132709.","journal-title":"Journal of Neurology"},{"key":"1464_CR18","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abg0470","volume":"7","author":"J Zhou","year":"2021","unstructured":"Zhou, J., et al. (2021). m6A demethylase ALKBH5 controls CD4+ T cell pathogenicity and promotes autoimmunity. Science Advances, 7, eabg0470.","journal-title":"Science Advances"},{"issue":"4","key":"1464_CR19","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.jcmgh.2020.07.001","volume":"10","author":"TX Lu","year":"2020","unstructured":"Lu, T. X., et al. (2020). A New Model of Spontaneous Colitis in Mice Induced by Deletion of an RNA m(6)A Methyltransferase Component METTL14 in T Cells. Cellular and Molecular Gastroenterology and Hepatology, 10(4), 747\u2013761.","journal-title":"Cellular and Molecular Gastroenterology and Hepatology"},{"issue":"7667","key":"1464_CR20","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nature23450","volume":"548","author":"HB Li","year":"2017","unstructured":"Li, H. B., et al. (2017). m(6)A mRNA methylation controls T cell homeostasis by targeting the IL-7\/STAT5\/SOCS pathways. Nature, 548(7667), 338\u2013342.","journal-title":"Nature"},{"issue":"1","key":"1464_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21594-6","volume":"12","author":"Y Yao","year":"2021","unstructured":"Yao, Y., et al. (2021). METTL3-dependent m(6)A modification programs T follicular helper cell differentiation. Nature Communications, 12(1), 1333.","journal-title":"Nature Communications"},{"issue":"2","key":"1464_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/cr.2018.7","volume":"28","author":"J Tong","year":"2018","unstructured":"Tong, J., et al. (2018). m(6)A mRNA methylation sustains Treg suppressive functions. Cell Research, 28(2), 253\u2013256.","journal-title":"Cell Research"},{"issue":"9","key":"1464_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1298","volume":"8","author":"Q Luo","year":"2020","unstructured":"Luo, Q., et al. (2020). The study of METTL14, ALKBH5, and YTHDF2 in peripheral blood mononuclear cells from systemic lupus erythematosus. Molecular Genetics and Genomic Medicine, 8(9), e1298.","journal-title":"Molecular Genetics and Genomic Medicine"},{"key":"1464_CR24","doi-asserted-by":"publisher","first-page":"8193895","DOI":"10.1155\/2020\/8193895","volume":"2020","author":"Q Luo","year":"2020","unstructured":"Luo, Q., et al. (2020). Decreased Peripheral Blood ALKBH5 Correlates with Markers of Autoimmune Response in Systemic Lupus Erythematosus. Disease Markers, 2020, 8193895.","journal-title":"Disease Markers"},{"issue":"1","key":"1464_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13075-022-02732-x","volume":"24","author":"X Zhao","year":"2022","unstructured":"Zhao, X., et al. (2022). N6-methyladenosine-dependent modification of circGARS acts as a new player that promotes SLE progression through the NF-kappaB\/A20 axis. Arthritis Research and Therapy, 24(1), 37.","journal-title":"Arthritis Research and Therapy"},{"key":"1464_CR26","doi-asserted-by":"publisher","first-page":"724837","DOI":"10.3389\/fcell.2021.724837","volume":"9","author":"H Zhao","year":"2021","unstructured":"Zhao, H., et al. (2021). Integrative Analysis of m(6)A Regulator-Mediated RNA Methylation Modification Patterns and Immune Characteristics in Lupus Nephritis. Frontiers in Cell and Developmental Biology, 9, 724837.","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"1464_CR27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.molimm.2017.11.009","volume":"93","author":"L Li","year":"2018","unstructured":"Li, L., et al. (2018). Potential link between m(6)A modification and systemic lupus erythematosusion and systemiclupus erythematosus. Molecular Immunology, 93, 55\u201363.","journal-title":"Molecular Immunology"},{"key":"1464_CR28","doi-asserted-by":"publisher","first-page":"591629","DOI":"10.3389\/fcell.2020.591629","volume":"8","author":"YN Wang","year":"2020","unstructured":"Wang, Y. N., & Jin, H. Z. (2020). Transcriptome-Wide m(6)A Methylation in Skin Lesions From Patients With Psoriasis Vulgaris. Frontiers in Cell and Developmental Biology, 8, 591629.","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"1464_CR29","doi-asserted-by":"publisher","unstructured":"De Jesus, D. F., et al. (2021). 287-OR_ M6A mRNA Methylation Regulates the Innate Immune Response in Human \u00df-\u00adCells. Diabetes, 70, https:\/\/doi.org\/10.2337\/db21-287-OR.","DOI":"10.2337\/db21-287-OR"},{"key":"1464_CR30","doi-asserted-by":"crossref","unstructured":"McFadden, M. J., et al. (2021). FTO Suppresses STAT3 Activation and Modulates Proinflammatory Interferon-Stimulated Gene Expression. Journal of Molecular Biology, 434, 167247.","DOI":"10.1016\/j.jmb.2021.167247"},{"key":"1464_CR31","doi-asserted-by":"publisher","first-page":"154702","DOI":"10.1016\/j.metabol.2021.154702","volume":"116","author":"X Li","year":"2021","unstructured":"Li, X., et al. (2021). METTL3 is required for maintaining beta-cell function. Metabolism, 116, 154702.","journal-title":"Metabolism"},{"key":"1464_CR32","first-page":"187","volume":"43","author":"J Christiansen","year":"2009","unstructured":"Christiansen, J., et al. (2009). IGF2 mRNA-binding protein 2: biological function and putative role in type 2 diabetes. Stem Cells International, 43, 187\u2013195.","journal-title":"Stem Cells International"},{"issue":"9","key":"1464_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-9-59","volume":"3","author":"DK Sanghera","year":"2008","unstructured":"Sanghera, D. K., et al. (2008). Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTO variants confer a significant risk. BMC Medical Genetics, 3(9), 59.","journal-title":"BMC Medical Genetics"},{"key":"1464_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-11-81","volume":"11","author":"X Han","year":"2010","unstructured":"Han, X., et al. (2010). Implication of genetic variants near SLC30A8, HHEX, CDKAL1, CDKN2A\/B, IGF2BP2, FTO, TCF2, KCNQ1, and WFS1 in type 2 diabetes in a Chinese population. BMC Medical Genetics, 11, 81.","journal-title":"BMC Medical Genetics"},{"issue":"1","key":"1464_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-01799-x","volume":"21","author":"J Wang","year":"2021","unstructured":"Wang, J., Chen, L., & Qiang, P. (2021). The role of IGF2BP2, an m6A reader gene, in human metabolic diseases and cancers. Cancer Cell International, 21(1), 99.","journal-title":"Cancer Cell International"},{"issue":"5","key":"1464_CR36","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jdiacomp.2012.05.012","volume":"26","author":"T Gu","year":"2012","unstructured":"Gu, T., et al. (2012). IGF2BP2 and IGF2 genetic effects in diabetes and diabetic nephropathy. Journal of Diabetes and its Complications, 26(5), 393\u2013398.","journal-title":"Journal of Diabetes and its Complications"},{"key":"1464_CR37","doi-asserted-by":"publisher","first-page":"9943743","DOI":"10.1155\/2021\/9943743","volume":"2021","author":"X Xia","year":"2021","unstructured":"Xia, X., Yang, J., & Wang, S. (2021). Follicular Regulatory T Cells in Systemic Lupus Erythematosus. Journal of Immunology Research, 2021, 9943743.","journal-title":"Journal of Immunology Research"},{"key":"1464_CR38","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.molcel.2016.05.041","volume":"63","author":"P Wang","year":"2016","unstructured":"Wang, P., Doxtader, K. A., & Nam, Y. (2016). Structural basis for cooperative function of Mettl3 and Mettl14 methyltransferases. Moleular Cell, 63, 306\u2013317.","journal-title":"Moleular Cell"},{"issue":"2","key":"1464_CR39","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/cr.2014.3","volume":"24","author":"X-L Ping","year":"2014","unstructured":"Ping, X.-L., et al. (2014). Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Research, 24(2), 177\u2013189.","journal-title":"Cell Research"},{"issue":"4","key":"1464_CR40","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1261\/rna.064063.117","volume":"24","author":"E Sch\u00f6ller","year":"2018","unstructured":"Sch\u00f6ller, E., et al. (2018). Interactions, localization, and phosphorylation of the m 6 A generating METTL3-METTL14-WTAP complex. RNA, 24(4), 499\u2013512.","journal-title":"RNA"},{"issue":"5","key":"1464_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101248","volume":"297","author":"K Horiuchi","year":"2021","unstructured":"Horiuchi, K., Kawamura, T., & Hamakubo, T. (2021). Wilms\u2019 tumor 1-associating protein complex regulates alternative splicing and polyadenylation at potential G-quadruplex-forming splice site sequences. Journal of Biological Chemistry, 297(5), 101248.","journal-title":"Journal of Biological Chemistry"},{"issue":"6","key":"1464_CR42","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.molcel.2018.02.015","volume":"69","author":"J Wen","year":"2018","unstructured":"Wen, J., et al. (2018). Zc3h13 Regulates Nuclear RNA m 6 A Methylation and Mouse Embryonic Stem Cell Self-Renewal. Molecular Cell, 69(6), 1028\u20131038.","journal-title":"Molecular Cell"},{"key":"1464_CR43","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41421-018-0019-0","volume":"4","author":"Y Yue","year":"2018","unstructured":"Yue, Y., et al. (2018). VIRMA mediates preferential m 6 A mRNA methylation in 3\u2019UTR and near stop codon and associates with alternative polyadenylation. Cell Discovery, 4, 10.","journal-title":"Cell Discovery"},{"issue":"1","key":"1464_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1106-z","volume":"18","author":"T Lan","year":"2019","unstructured":"Lan, T., et al. (2019). KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3. Molecular Cancer, 18(1), 186.","journal-title":"Molecular Cancer"},{"issue":"10","key":"1464_CR45","doi-asserted-by":"publisher","first-page":"7420","DOI":"10.1002\/jcp.29645","volume":"235","author":"R Miao","year":"2020","unstructured":"Miao, R., et al. (2020). KIAA1429 regulates cell proliferation by targeting c-Jun messenger RNA directly in gastric cancer. Journal of Cellular Physiology, 235(10), 7420\u20137432.","journal-title":"Journal of Cellular Physiology"},{"issue":"6225","key":"1464_CR46","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1126\/science.1261417","volume":"347","author":"S Geula","year":"2016","unstructured":"Geula, S., et al. (2016). Stem cells. m6A mRNA methylation facilitates resolution of na\u00efve pluripotency toward differentiation. Science, 347(6225), 1002\u20131006.","journal-title":"Science"},{"issue":"11","key":"1464_CR47","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1136\/gutjnl-2016-312439","volume":"66","author":"S Zundler","year":"2017","unstructured":"Zundler, S., et al. (2017). Blockade of aEb7 integrin suppresses accumulation of CD8+ and Th9 lymphocytes from patients with IBD in the inflamed gut in vivo. Gut, 66(11), 1936\u20131948.","journal-title":"Gut"},{"issue":"1","key":"1464_CR48","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.bbrc.2020.04.088","volume":"527","author":"M Yao","year":"2020","unstructured":"Yao, M., et al. (2020). N 6-methyladenosine modifications enhance enterovirus 71 ORF translation through METTL3 cytoplasmic distribution. Biochemical And Biophysical Research Communications, 527(1), 297\u2013304.","journal-title":"Biochemical And Biophysical Research Communications"},{"issue":"3","key":"1464_CR49","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.molcel.2016.03.021","volume":"62","author":"S Lin","year":"2016","unstructured":"Lin, S., et al. (2016). The m 6 A methyltransferase METTL3 promotes translation in human cancer cells. Molecular Cell, 62(3), 335\u2013345.","journal-title":"Molecular Cell"},{"issue":"7724","key":"1464_CR50","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41586-018-0538-8","volume":"561","author":"J Choe","year":"2018","unstructured":"Choe, J., et al. (2018). mRNA circularization by METTL3\u2013eIF3h enhances translation and promotes oncogenesis. Nature, 561(7724), 556\u2013560.","journal-title":"Nature"},{"issue":"15","key":"1464_CR51","doi-asserted-by":"publisher","first-page":"5028","DOI":"10.1002\/anie.201900901","volume":"58","author":"L-J Xie","year":"2019","unstructured":"Xie, L.-J., et al. (2019). Identification of Flavin Mononucleotide as a Cell-Active Artificial N6-methyladenosine RNA Demethylase. Angewandte Chemie International Edtion, 58(15), 5028\u20135032.","journal-title":"Angewandte Chemie International Edtion"},{"issue":"13","key":"1464_CR52","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.7150\/thno.31868","volume":"9","author":"X-C Li","year":"2019","unstructured":"Li, X.-C., et al. (2019). The m6A demethylase ALKBH5 controls trophoblast invasion at the maternal-fetal interface by regulating the stability of CYR61 mRNA. Theranostics, 9(13), 3853\u20133865.","journal-title":"Theranostics"},{"issue":"1","key":"1464_CR53","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.molcel.2012.10.015","volume":"49","author":"G Zheng","year":"2013","unstructured":"Zheng, G., et al. (2013). ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Molecular Cell, 49(1), 18\u201329.","journal-title":"Molecular Cell"},{"issue":"3","key":"1464_CR54","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s13105-019-00690-8","volume":"75","author":"J Zhang","year":"2019","unstructured":"Zhang, J., et al. (2019). ALKBH5 promotes invasion and metastasis of gastric cancer by decreasing methylation of the lncRNA NEAT1. Journal of Physiology and Biochemistry, 75(3), 379\u2013389.","journal-title":"Journal of Physiology and Biochemistry"},{"issue":"10","key":"1464_CR55","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/ni.3830","volume":"18","author":"Q Zheng","year":"2017","unstructured":"Zheng, Q., et al. (2017). The RNA helicase DDX46 inhibits innate immunity by entrapping m6Ademethylated antiviral transcripts in the nucleus. Nature Immunology, 18(10), 1094\u20131103.","journal-title":"Nature Immunology"},{"key":"1464_CR56","doi-asserted-by":"publisher","first-page":"109553","DOI":"10.1016\/j.cellsig.2020.109553","volume":"69","author":"X Gu","year":"2020","unstructured":"Gu, X., et al. (2020). N6-methyladenosine demethylase FTO promotes M1 and M2 macrophage activation. Cell Signal, 69, 109553.","journal-title":"Cell Signal"},{"issue":"1","key":"1464_CR57","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1038\/s41467-019-10669-0","volume":"10","author":"S Yang","year":"2019","unstructured":"Yang, S., et al. (2019). m(6)A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade. Nature Communication, 10(1), 2782.","journal-title":"Nature Communication"},{"issue":"1","key":"1464_CR58","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ccell.2016.11.017","volume":"31","author":"Z Li","year":"2017","unstructured":"Li, Z., et al. (2017). FTO plays an oncogenic role in acute myeloid leukemia as a N(6)-methyladenosine RNA demethylase. Cancer Cell, 31(1), 127\u2013141.","journal-title":"Cancer Cell"},{"issue":"7481","key":"1464_CR59","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature12730","volume":"505","author":"X Wang","year":"2014","unstructured":"Wang, X., et al. (2014). N6-methyladenosine-dependent regulation of messenger RNA stability. Nature, 505(7481), 117\u2013120.","journal-title":"Nature"},{"issue":"4","key":"1464_CR60","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.cell.2015.10.012","volume":"163","author":"KD Meyer","year":"2015","unstructured":"Meyer, K. D., et al. (2015). 5\u2032 UTR m6A promotes cap-independent translation. Cell, 163(4), 999\u20131010.","journal-title":"Cell"},{"key":"1464_CR61","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/cr.2017.15","volume":"27","author":"H Shi","year":"2017","unstructured":"Shi, H., et al. (2017). YTHDF3 facilitates translation and decay of N 6 -methyladenosine-modified RNA. Cell Research, 27, 315\u2013328.","journal-title":"Cell Research"},{"key":"1464_CR62","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/cr.2017.10","volume":"27","author":"A Li","year":"2017","unstructured":"Li, A., et al. (2017). Cytoplasmic m 6 A reader YTHDF3 promotes mRNA translation. Cell Research, 27, 444\u2013447.","journal-title":"Cell Research"},{"issue":"3","key":"1464_CR63","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1073\/pnas.1812536116","volume":"116","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y., et al. (2019). RNA-binding protein YTHDF3 suppresses interferon-dependent antiviral responses by promoting FOXO3 translation. Proceedings of the National Academy of Sciences of the United States of America, 116(3), 976\u2013981.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"1464_CR64","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.cell.2015.05.014","volume":"161","author":"X Wang","year":"2015","unstructured":"Wang, X., et al. (2015). N(6)-methyladenosine Modulates Messenger RNA Translation Efficiency. Cell, 161(6), 1388\u20131399.","journal-title":"Cell"},{"issue":"7765","key":"1464_CR65","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41586-019-1374-1","volume":"571","author":"RJ Ries","year":"2019","unstructured":"Ries, R. J., et al. (2019). m 6 A enhances the phase separation potential of mRNA. Nature, 571(7765), 424\u2013428.","journal-title":"Nature"},{"issue":"2","key":"1464_CR66","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.molcel.2017.09.021","volume":"68","author":"MN Wojtas","year":"2017","unstructured":"Wojtas, M. N., et al. (2017). Regulation of m 6 A Transcripts by the 3\u2019\u21925\u2019 RNA Helicase YTHDC2 Is Essential for a Successful Meiotic Program in the Mammalian Germline. Molecular Cell, 68(2), 374\u2013387.","journal-title":"Molecular Cell"},{"issue":"4","key":"1464_CR67","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.molcel.2016.01.012","volume":"61","author":"W Xiao","year":"2016","unstructured":"Xiao, W., et al. (2016). Nuclear m(6)A Reader YTHDC1 Regulates mRNA Splicing. Molecular Cell, 61(4), 507\u2013519.","journal-title":"Molecular Cell"},{"key":"1464_CR68","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.26116","volume":"6","author":"AS Bailey","year":"2017","unstructured":"Bailey, A. S., et al. (2017). The conserved RNA helicase YTHDC2 regulates the transition from proliferation to differentiation in the germline. Elife, 6, e26116.","journal-title":"Elife"},{"issue":"9","key":"1464_CR69","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/cr.2017.99","volume":"27","author":"PJ Hsu","year":"2017","unstructured":"Hsu, P. J., et al. (2017). Ythdc2 is an N6-methyladenosine binding protein that regulates mammalian spermatogenesis. Cell Research, 27(9), 1115\u20131127.","journal-title":"Cell Research"},{"key":"1464_CR70","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.30919","volume":"7","author":"D Jain","year":"2018","unstructured":"Jain, D., et al. (2018). ketu mutant mice uncover an essential meiotic function for the ancient RNA helicase YTHDC2. Elife, 7, e30919.","journal-title":"Elife"},{"issue":"21","key":"1464_CR71","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1101\/gad.9.21.2659","volume":"9","author":"H Min","year":"1995","unstructured":"Min, H., Chan, R. C., & Black, D. L. (1995). The generally expressed hnRNP F is involved in a neural-specific pre-mRNA splicing event. Genes Development, 9(21), 2659\u20132671.","journal-title":"Genes Development"},{"issue":"7540","key":"1464_CR72","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/nature14234","volume":"518","author":"N Liu","year":"2015","unstructured":"Liu, N., et al. (2015). N(6)-methyladenosine- dependent RNA structural switches regulate RNA- protein interactions. Nature, 518(7540), 560\u2013564.","journal-title":"Nature"},{"issue":"10","key":"1464_CR73","doi-asserted-by":"publisher","first-page":"6051","DOI":"10.1093\/nar\/gkx141","volume":"45","author":"N Liu","year":"2017","unstructured":"Liu, N., et al. (2017). N6-methyladenosine alters RNA structure to regulate binding of a low-complexity protein. Nucleic Acids Research, 45(10), 6051\u20136063.","journal-title":"Nucleic Acids Research"},{"issue":"6","key":"1464_CR74","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.cell.2015.08.011","volume":"162","author":"CR Alarc\u00f3n","year":"2015","unstructured":"Alarc\u00f3n, C. R., et al. (2015). HNRNPA2B1 Is a Mediator of m(6)A-Dependent Nuclear RNA Processing Events. Cell, 162(6), 1299\u20131308.","journal-title":"Cell"},{"issue":"1","key":"1464_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02770-z","volume":"9","author":"B Wu","year":"2018","unstructured":"Wu, B., et al. (2018). Molecular basis for the specific and multivariant recognitions of RNA substrates by human hnRNP A2\/B1. Nature Communications, 9(1), 420.","journal-title":"Nature Communications"},{"issue":"10","key":"1464_CR76","doi-asserted-by":"publisher","first-page":"8870","DOI":"10.1038\/nsmb.3462","volume":"24","author":"RR Edupuganti","year":"2017","unstructured":"Edupuganti, R. R., et al. (2017). N(6)-methyladenosine (m(6)A) recruits and repels proteins to regulate mRNA homeostasis. Nature Structural & Molecular Biology, 24(10), 8870\u20138878.","journal-title":"Nature Structural & Molecular Biology"},{"issue":"3","key":"1464_CR77","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","volume":"20","author":"H Huang","year":"2018","unstructured":"Huang, H., et al. (2018). Recognition of RNA N6-methyladenosine by IGF2BP Proteins Enhances mRNA Stability and Translation. Nature Cell Biology, 20(3), 285\u2013295.","journal-title":"Nature Cell Biology"},{"issue":"11","key":"1464_CR78","first-page":"1159","volume":"25","author":"N Dai","year":"2011","unstructured":"Dai, N., et al. (2011). mTOR phosphorylates IMP2 to promote IGF2 mRNA translation by internal ribosomal entry. GENES &. Development, 25(11), 1159\u20131172.","journal-title":"Development"},{"issue":"7554","key":"1464_CR79","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature14267","volume":"522","author":"AS Lee","year":"2015","unstructured":"Lee, A. S., Kranzusch, P. J., & Cate, J. H. (2015). Cate, eIF3 targets cell proliferation mRNAs for translational activation or repression. Nature, 522(7554), 111\u2013114.","journal-title":"Nature"},{"key":"1464_CR80","doi-asserted-by":"crossref","unstructured":"Grenov, A. C. et al. (2020). B Cell Division Capacity in Germinal Centers Depends on Myc Transcript Stabilization Through m6A mRNA Methylation and IGF2BP3 Functions. BioRxiv, https:\/\/www.biorxiv.org\/content\/10.1101\/2020.09.08.287433v1.full.","DOI":"10.1101\/2020.09.08.287433"},{"issue":"1","key":"1464_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09903-6","volume":"10","author":"H Wang","year":"2019","unstructured":"Wang, H., et al. (2019). Mettl3-mediated mRNA m(6)A methylation promotes dendritic cell activation. Nature Communications, 10(1), 1898.","journal-title":"Nature Communications"},{"key":"1464_CR82","doi-asserted-by":"publisher","first-page":"1433323","DOI":"10.1155\/2022\/1433323","volume":"2022","author":"M Liu","year":"2022","unstructured":"Liu, M., et al. (2022). 29 m(6)A-RNA Methylation (Epitranscriptomic) Regulators Are Regulated in 41 Diseases including Atherosclerosis and Tumors Potentially via ROS Regulation - 102 Transcriptomic Dataset Analyses. Journal of Immunology Research, 2022, 1433323.","journal-title":"Journal of Immunology Research"},{"key":"1464_CR83","doi-asserted-by":"publisher","first-page":"752736","DOI":"10.3389\/fimmu.2021.752736","volume":"12","author":"X Zhao","year":"2022","unstructured":"Zhao, X., et al. (2022). Exploration of Potential Integrated Models of N6-Methyladenosine Immunity in Systemic Lupus Erythematosus by Bioinformatic Analyses. Frontiers in Immunology, 12, 752736.","journal-title":"Frontiers in Immunology"},{"key":"1464_CR84","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.molimm.2022.01.006","volume":"143","author":"J Wu","year":"2022","unstructured":"Wu, J., et al. (2022). Involvement of N6-methyladenosine modifications of long noncoding RNAs in systemic lupus erythematosus. Molecular Immunology, 143, 77\u201384.","journal-title":"Molecular Immunology"},{"issue":"27","key":"1464_CR85","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.2174\/1381612828666220617154204","volume":"28","author":"L-J Deng","year":"2022","unstructured":"Deng, L.-J., et al. (2022). ALKBH5 Expression could Affect the Function of T Cells in Systemic Lupus Erythematosus Patients: A Case-control Study. Current Pharmaceutical Design, 28(27), 2270\u20132278.","journal-title":"Current Pharmaceutical Design"},{"key":"1464_CR86","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2147\/JIR.S439779","volume":"17","author":"Y Tian","year":"2024","unstructured":"Tian, Y., et al. (2024). Identification of m6A-Related Biomarkers in Systemic Lupus Erythematosus: A Bioinformation-Based Analysis. Journal of Inflammation Research, 17, 507\u2013526.","journal-title":"Journal of Inflammation Research"},{"issue":"1","key":"1464_CR87","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s10020-023-00643-4","volume":"29","author":"S Lu","year":"2023","unstructured":"Lu, S., et al. (2023). m6A methyltransferase METTL3 programs CD4+ T-cell activation and effector T-cell differentiation in systemic lupus erythematosus. Molecular Medicine, 29(1), 46.","journal-title":"Molecular Medicine"},{"issue":"1","key":"1464_CR88","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-024-03549-3","volume":"25","author":"D Li","year":"2024","unstructured":"Li, D., et al. (2024). Analysis of m6A-regulated genes and subtype classification in lupus nephritis. BMC Nephrology, 25(1), 119.","journal-title":"BMC Nephrology"},{"key":"1464_CR89","doi-asserted-by":"publisher","first-page":"676082","DOI":"10.3389\/fimmu.2021.676082","volume":"12","author":"X Ding","year":"2021","unstructured":"Ding, X., Ren, Y., & He, X. (2021). IFN-I Mediates Lupus Nephritis From the Beginning to Renal Fibrosis. Frontiers in Immunology, 12, 676082.","journal-title":"Frontiers in Immunology"},{"issue":"3","key":"1464_CR90","doi-asserted-by":"publisher","first-page":"6740","DOI":"10.1080\/21655979.2022.2045836","volume":"13","author":"B Wang","year":"2022","unstructured":"Wang, B., et al. (2022). Emodin relieves the inflammation and pyroptosis of lipopolysaccharide-treated 1321N1 cells by regulating methyltransferase-like 3 -mediated NLR family pyrin domain containing 3 expression. Bioengineered, 13(3), 6740\u20136749.","journal-title":"Bioengineered"},{"key":"1464_CR91","doi-asserted-by":"publisher","first-page":"113367","DOI":"10.1016\/j.biopha.2022.113367","volume":"153","author":"R Xu","year":"2022","unstructured":"Xu, R., et al. (2022). The methyltransferase METTL3-mediated fatty acid metabolism revealed the mechanism of cinnamaldehyde on alleviating steatosis. Biomedicine & Pharmacotherapy, 153, 113367.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"2","key":"1464_CR92","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3945\/ajcn.115.123414","volume":"103","author":"MV Avesaat","year":"2016","unstructured":"Avesaat, M. V., et al. (2016). Capsaicin-induced satiety is associated with gastrointestinal distress but not with the release of satiety hormones. The American Journal of Clinical Nutrition, 103(2), 305\u2013313.","journal-title":"The American Journal of Clinical Nutrition"},{"key":"1464_CR93","doi-asserted-by":"publisher","first-page":"667644","DOI":"10.3389\/fphar.2021.667644","volume":"12","author":"B-H Liu","year":"2021","unstructured":"Liu, B.-H., et al. (2021). Total Flavones of Abelmoschus manihot Ameliorates Podocyte Pyroptosis and Injury in High GlucoseConditions by Targeting METTL3-Dependent m(6)A Modification-Mediated NLRP3-Inflammasome Activation and PTEN\/PI3K\/Akt Signaling. Frontiers in Pharmacology, 12, 667644.","journal-title":"Frontiers in Pharmacology"},{"key":"1464_CR94","doi-asserted-by":"crossref","unstructured":"Abo-Dya, N. E. & Issahaku, A. R. (2023). Leveraging Flavonoids as Potential Inhibitors of METTL3 in Combating Cancer: A Combined Structure-Based Drug Design and DFT Approach. ChemistrySelect. 8(45), e202303481.","DOI":"10.1002\/slct.202303481"},{"key":"1464_CR95","doi-asserted-by":"publisher","first-page":"878135","DOI":"10.3389\/fphar.2022.878135","volume":"13","author":"Y Du","year":"2022","unstructured":"Du, Y., et al. (2022). Discovery of METTL3 Small Molecule Inhibitors by Virtual Screening of Natural Products. Frontiers in Pharmacology, 13, 878135.","journal-title":"Frontiers in Pharmacology"},{"issue":"21","key":"1464_CR96","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1021\/acs.accounts.3c00451","volume":"56","author":"Y Huang","year":"2023","unstructured":"Huang, Y., et al. (2023). Chemical Inhibitors Targeting the Oncogenic m6A Modifying Proteins. Accounts of Chemical Research, 56(21), 3010\u20133022.","journal-title":"Accounts of Chemical Research"},{"issue":"3","key":"1464_CR97","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.3390\/ijms22031453","volume":"22","author":"V Izquierdo","year":"2021","unstructured":"Izquierdo, V., et al. (2021). Resveratrol Supplementation Attenuates Cognitive and Molecular Alterations under Maternal High-Fat Diet Intake: Epigenetic Inheritance over Generations. International Journal of Molecular Sciences, 22(3), 1453.","journal-title":"International Journal of Molecular Sciences"},{"key":"1464_CR98","doi-asserted-by":"publisher","first-page":"568006","DOI":"10.3389\/fphar.2020.568006","volume":"11","author":"J Wu","year":"2020","unstructured":"Wu, J., et al. (2020). Resveratrol attenuates high-fat diet induced hepatic lipid homeostasis disorder and decreases m6A RNA methylation. Frontiers in Pharmacology, 11, 568006.","journal-title":"Frontiers in Pharmacology"},{"key":"1464_CR99","doi-asserted-by":"publisher","first-page":"568006","DOI":"10.3389\/fphar.2020.568006","volume":"11","author":"J Wu","year":"2020","unstructured":"Wu, J., et al. (2020). Inhibition of METTL3 attenuates renal injury and inflammation by alleviating TAB3 m6A modifications via IGF2BP2-dependent mechanisms. Frontiers in Pharmacology, 11, 568006.","journal-title":"Frontiers in Pharmacology"},{"key":"1464_CR100","doi-asserted-by":"publisher","first-page":"116182","DOI":"10.1016\/j.bone.2021.116182","volume":"154","author":"Y He","year":"2022","unstructured":"He, Y., et al. (2022). Mettl3 inhibits the apoptosis and autophagy of chondrocytes in inflammation through mediating Bcl2 stability via Ythdf1-mediated m(6)A modification. Bone, 154, 116182.","journal-title":"Bone"},{"key":"1464_CR101","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","volume":"593","author":"E Yankova","year":"2021","unstructured":"Yankova, E., et al. (2021). Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Nature, 593, 597\u2013601.","journal-title":"Nature"},{"issue":"Suppl 1","key":"1464_CR102","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1182\/blood-2023-189993","volume":"143","author":"G Fraser","year":"2023","unstructured":"Fraser, G., et al. (2023). EP102: Pharmacological Inhibition of METTL3 Elicits Tumor Growth Inhibition In Vivo and Demonstrates Synergy with Venetoclax in Various AML Models. Blood, 143(Suppl 1), 2263.","journal-title":"Blood"},{"issue":"3","key":"1464_CR103","first-page":"783","volume":"83","author":"J-H Lee","year":"2022","unstructured":"Lee, J.-H., et al. (2022). Discovery of substituted indole derivatives as allosteric inhibitors of m 6 A-RNA methyltransferase, METTL3-14 complex. Drug Development Research, 83(3), 783\u2013799.","journal-title":"Drug Development Research"},{"issue":"1","key":"1464_CR104","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.chembiol.2023.12.009","volume":"31","author":"W Du","year":"2024","unstructured":"Du, W., et al. (2024). Discovery of a PROTAC degrader for METTL3-METTL14 complex. Cell Chemical Biology, 31(1), 177\u2013183(e17).","journal-title":"Cell Chemical Biology"},{"issue":"4","key":"1464_CR105","first-page":"1424","volume":"15","author":"L Je-Heon","year":"2022","unstructured":"Je-Heon, L., et al. (2022). Eltrombopag as an Allosteric Inhibitor of the METTL3-14 Complex Affecting the m 6 A Methylation of RNA in Acute Myeloid Leukemia Cells. Pharmaceuticals, 15(4), 1424\u20138247.","journal-title":"Pharmaceuticals"},{"issue":"1","key":"1464_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cbdd.14051","volume":"100","author":"H Takahashi","year":"2022","unstructured":"Takahashi, H., et al. (2022). Discovery of two novel ALKBH5 selective inhibitors that exhibit uncompetitive or competitive type and suppress the growth activity of glioblastoma multiforme. Chemical Biology & Drug Design, 100(1), 1\u201312.","journal-title":"Chemical Biology & Drug Design"},{"issue":"5","key":"1464_CR107","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1016\/j.gendis.2022.09.008","volume":"10","author":"S He","year":"2022","unstructured":"He, S., et al. (2022). FTO-mediated m6A modification alleviates autoimmune uveitis by regulating microglia phenotypes via the GPC4\/TLR4\/NF-\u03baB signaling axis. Genes & Diseases, 10(5), 2179\u20132193.","journal-title":"Genes & Diseases"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-024-01464-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-024-01464-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-024-01464-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T17:09:56Z","timestamp":1732036196000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-024-01464-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,2]]},"references-count":107,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1464"],"URL":"https:\/\/doi.org\/10.1007\/s12013-024-01464-w","relation":{},"ISSN":["1085-9195","1559-0283"],"issn-type":[{"value":"1085-9195","type":"print"},{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,2]]},"assertion":[{"value":"25 July 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}